Page last updated: 2024-08-25

methotrexate and Myxedema

methotrexate has been researched along with Myxedema in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altmeyer, P; Breuckmann, F; Freitag, M; Kreuter, A; Rotterdam, S; Stuecker, M1
Bergfeld, WF; Guirguis, MN; Hanke, CW; Lewis, LJ1
Hödl, S1
Civatte, J; Clauvel, JP; Danon, F; Degos, R1
Depisch, D; Höfer, R; Schatz, H1

Other Studies

5 other study(ies) available for methotrexate and Myxedema

ArticleYear
Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: case report.
    BMC dermatology, 2004, Sep-22, Volume: 4, Issue:1

    Topics: Adult; Chronic Disease; Erythema; Female; Folic Acid; Glycosaminoglycans; Humans; Immunohistochemistry; Methotrexate; Myxedema; Phototherapy; Scleroderma, Localized; Skin

2004
Pretibial myxedema (elephantiasic form): treatment with cytotoxic therapy.
    Cleveland Clinic quarterly, 1983,Summer, Volume: 50, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leg Dermatoses; Male; Mechlorethamine; Melphalan; Methotrexate; Myxedema

1983
[Lichen myxedematosus and scleromyxedema].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1982, Volume: 33, Issue:7

    Topics: Cyclophosphamide; Humans; Lichen Planus; Male; Methotrexate; Middle Aged; Mucins; Myxedema; Scleroderma, Localized; Skin

1982
[Globulin anomalies in skin mucinosis].
    Bulletin de la Societe francaise de dermatologie et de syphiligraphie, 1970, Volume: 77, Issue:5

    Topics: Adult; Aged; Blood Protein Disorders; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Myxedema; Scleroderma, Systemic; Serum Globulins; Skin Diseases

1970
[The effect of immunosuppressive therapy on the long acting thyroid stimulator (LATS) and the clinical picture in patients with localized myxedema and exophthalmus].
    Wiener klinische Wochenschrift, 1969, Jan-03, Volume: 81, Issue:1

    Topics: Chlorambucil; Graves Disease; Humans; Immunosuppressive Agents; Long-Acting Thyroid Stimulator; Mercaptopurine; Methotrexate; Myxedema

1969